They then transfected a siRNA library targeted to the differentially expressed genes in four diverse mut-BRAF CRC cell lines, finding that only the targeting of HSPA5—the gene encoding the master regulator of UPR GRP78—had a significant inhibitory effect on the survival of cell lines. Here, BRAF is linked to colorectal carcinoma.